Synonyms: OMP-21M18 | OMP21M18
Compound class:
Antibody
Comment: Demcizumab is a humanised IgG2 monoclonal antibody targeting DLL4 (delta like canonical Notch ligand 4), a membrane bound Notch receptor ligand expressed predominantly on vascular endothelial cells.
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. A BLAST search using the peptide sequence of the variable region of the heavy chain forming demcizumab reveals US7750124 B2 as the covering patent [2]. |
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
9572 | demcizumab |
Synonyms ![]() |
OMP-21M18 | OMP21M18 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 415 |
Other databases | |
GtoPdb PubChem SID | 252166661 |
Search PubMed clinical trials | demcizumab |
Search PubMed titles | demcizumab |
Search PubMed titles/abstracts | demcizumab |
Wikipedia | Demcizumab |